About this trial
Cerebellar ataxia is a form of ataxia originating in the cerebellum. Cerebellar ataxia can occur as a result of many diseases and may present with symptoms of an inability to coordinate balance, gait, extremity and eye movements. To understand the clinical and genetic characteristics of cerebellar ataxia, we establish a registered cohort to follow up Chinese patients with cerebellar ataxia.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients with cerebellar ataxia based on the diagnoses of tow neurologists
Relatives of patients with cerebellar ataxia
Unrelated healthy controls
Participants or legal guardian(s) willing and able to complete the informed consent process
Disqualifiers
Participants are unable to comply with trial procedures and visit schedule
Trial population
Patients with cerebellar ataxia who are diagnosed by tow neurologists in the Organization in South-East China for Cerebellar Ataxia Research (OSCCAR) from the First Affiliated Hospital of Fujian Medical University.
Trial design
Cohort
Prospective
Treatments tested in this trial
No intervention
Other interventionNo intervention
Treatment groups
Trial outcomes
Primary outcomes
The incidence of hereditary cerebellar ataxia
Look for the causative gene in the patient with cerebellar ataxia
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ning Wang, MD., PhD.
Lead sponsor
First Affiliated Hospital of Fujian Medical University
Sponsor institution